ANTHONY LUCCI to Mohs Surgery
This is a "connection" page, showing publications ANTHONY LUCCI has written about Mohs Surgery.
Connection Strength
0.035
-
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol. 2018 02; 19(2):181-193.
Score: 0.035